menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

An Overview of the 2020 American College of Cardiology Expert Consensus Decision Pathway on Novel Therapies for CV Risk Reduction in Patients With T2D

Program Information
Recommended

Program Information

An Overview of the 2020 American College of Cardiology Expert Consensus Decision Pathway on Novel Therapies for CV Risk Reduction in Patients With T2D
RestartResume

What does the updated 2020 ACC Expert Consensus Decision Pathway recommend when it comes to reducing the risk of cardiovascular events in patients with type 2 diabetes?

  • Sponsored by

  • Overview

    The 2020 American College of Cardiology Expert Consensus Decision Pathway provides a change in mindset for the cardiology field when it comes to treating patients with type 2 diabetes with established cardiovascular disease. Here to walk us through these updated recommendations is Dr. Joshua Stolker, an interventional cardiologist at Mercy Clinic Heart and Vascular in Saint Louis, Missouri.

    To view the 2020 American College of Cardiology Expert Consensus Decision Pathway click here.

    Novo Nordisk is a registered trademark of Novo Nordisk A/S.

    © 2021 Novo Nordisk All rights reserved. US20DI00430 January 2021

LIVE ON REACHMD RADIOBack to live radio

Loading...

Programs 3/7/21